Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MAHLUM, JONATHAN DAVIS | 1 | 51.6% | +21.2% |
| PATTERSON, SARAH COOPER | 1 | 57.1% | +59.5% |
| HELM, CARALYNNE E | 1 | 28.8% | +49.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17798143 | USE OF BMP INHIBITORS IN THE TREATMENT OF MOLAR PREGNANCY | MAHLUM, JONATHAN DAVIS | 2d overdue |
| 17587667 | ANTIBODY-POLYMER CONJUGATES | HELM, CARALYNNE E | 5d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17798143 | USE OF BMP INHIBITORS IN THE TREATMENT OF MOLAR PREGNANCY | MAHLUM, JONATHAN DAVIS | 2d overdue |
| 17587667 | ANTIBODY-POLYMER CONJUGATES | HELM, CARALYNNE E | 5d |
| 17775996 | ASC SPECKS IN CANCER IMMUNOTHERAPY | PATTERSON, SARAH COOPER | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1675 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17798143 | USE OF BMP INHIBITORS IN THE TREATMENT OF MOLAR PREGNANCY | MAHLUM, JONATHAN DAVIS | 1625 | §102§112 | Final Rejection | 2d overdue | Pending | Aug 08, 2022 |
| 17775996 | ASC SPECKS IN CANCER IMMUNOTHERAPY | PATTERSON, SARAH COOPER | 1675 | §112 | Final Rejection | — | Pending | May 11, 2022 |
| 17587667 | ANTIBODY-POLYMER CONJUGATES | HELM, CARALYNNE E | 1615 | §103§112 | Final Rejection | 5d | Pending | Jan 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial